Summary
Centene Corporation's 2005 Form 10-K reveals a company experiencing significant growth, primarily driven by its Medicaid Managed Care segment. The company successfully expanded its membership by 78% over two years and saw revenues increase by 50% in 2005 to $1.5 billion. This growth was fueled by strategic acquisitions, including a pharmacy benefits manager (US Script, Inc.) and a disease management provider (AirLogix, Inc.), as well as organic membership gains in existing states and new contract awards, such as in Georgia. The company's strategy centers on diversifying its business lines, addressing emerging state needs, increasing penetration in existing markets, and developing new state markets, particularly where Medicaid enrollment is mandated. Centene emphasizes its localized approach, deep Medicaid expertise, and collaborative relationships with states and providers as key competitive advantages. While growth is robust, investors should note the inherent risks associated with operating in a heavily regulated government-subsidized healthcare sector, including potential funding reductions, contract non-renewals, and evolving regulatory landscapes.
Key Highlights
- 1Revenue grew 50% to $1.5 billion in 2005, driven by a 78% increase in Medicaid Managed Care membership over two years.
- 2Successful acquisitions in 2005 included AirLogix, Inc. (disease management) and plans for US Script, Inc. (pharmacy benefits management) in early 2006, supporting business diversification.
- 3The company operates in seven states with a significant presence in Indiana, Texas, and Wisconsin, serving 871,900 members by the end of 2005.
- 4Centene's strategy focuses on diversification, expanding into new state markets with mandated managed care, and increasing penetration in existing markets through various growth initiatives.
- 5The company maintains strong relationships with providers and states, emphasizing a localized approach and specialized healthcare services for low-income populations.
- 6Despite strong revenue growth, the company operates with thin margins, as indicated by health benefits ratios (HBR) ranging from 81.7% for Medicaid/SCHIP to 97.5% for SSI.
- 7Key risks highlighted include dependence on government funding (Medicaid, SCHIP, SSI), potential contract terminations, regulatory changes, and the need to effectively manage medical and administrative costs.